JOUNCE THERAPEUTICS Trademark

Trademark Overview

On Wednesday, May 21, 2014, a trademark application was filed for JOUNCE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the JOUNCE THERAPEUTICS trademark a serial number of 86287754. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, October 6, 2021. This trademark is owned by Jounce Therapeutics, Inc.. The JOUNCE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceuticals for the treatment of oncological and immune system related diseases and disorders
jounce therapeutics

General Information

Serial Number86287754
Word MarkJOUNCE THERAPEUTICS
Filing DateWednesday, May 21, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, October 6, 2021
Registration Number4800711
Registration DateTuesday, August 25, 2015
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 24, 2015

Trademark Statements

Description of MarkThe mark consists of the words "JOUNCE THERAPEUTICS" in stylized letters with the word "JOUNCE" in larger stylized font above the word "THERAPEUTICS" with the letter "O" more pronounced and a stylized swoop design beneath the words.
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesResearch and development of pharmaceuticals for the treatment of oncological and immune system related diseases and disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 4, 2014
Primary Code042
First Use Anywhere DateThursday, December 11, 2014
First Use In Commerce DateThursday, December 11, 2014

Trademark Owner History

Party NameJounce Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAddison, TX 75001
Party NameJounce Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameJounce Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Trademark Events

Event DateEvent Description
Monday, September 8, 2014NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Saturday, May 24, 2014NEW APPLICATION ENTERED
Wednesday, June 4, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 5, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, September 5, 2014ASSIGNED TO EXAMINER
Monday, September 8, 2014EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Monday, September 8, 2014COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Monday, September 8, 2014EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Sunday, February 8, 2015ASSIGNED TO LIE
Wednesday, March 4, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 24, 2015PUBLISHED FOR OPPOSITION
Tuesday, March 24, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 19, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 15, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 30, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 9, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 9, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 10, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 17, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 14, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 23, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, July 24, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 25, 2015REGISTERED-PRINCIPAL REGISTER
Friday, October 26, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 15, 2015TEAS STATEMENT OF USE RECEIVED
Monday, June 15, 2015USE AMENDMENT FILED
Monday, July 20, 2015STATEMENT OF USE PROCESSING COMPLETE
Monday, June 15, 2015TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, July 20, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 26, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 25, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, October 6, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, October 6, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, June 24, 2021TEAS SECTION 8 & 15 RECEIVED
Wednesday, October 6, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 6, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 6, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 6, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 7, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Tuesday, May 7, 2024WITHDRAWAL OF ATTORNEY GRANTED
Sunday, August 25, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, May 6, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED

Related Keywords

therapeutics jounce system related diseases disorders immune oncological development pharmaceuticals treatment research